Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05275374
Title XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation (ENHANCE)
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Xynomic Pharmaceuticals, Inc.
Indications

colorectal cancer

thyroid gland cancer

melanoma

lung non-small cell carcinoma

Therapies

BI 882370 + Trametinib

BI 882370

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST